450 related articles for article (PubMed ID: 24380811)
1. The Rho-GEF Kalirin regulates bone mass and the function of osteoblasts and osteoclasts.
Huang S; Eleniste PP; Wayakanon K; Mandela P; Eipper BA; Mains RE; Allen MR; Bruzzaniti A
Bone; 2014 Mar; 60():235-45. PubMed ID: 24380811
[TBL] [Abstract][Full Text] [Related]
2. Thrombin receptor deficiency leads to a high bone mass phenotype by decreasing the RANKL/OPG ratio.
Tudpor K; van der Eerden BC; Jongwattanapisan P; Roelofs JJ; van Leeuwen JP; Bindels RJ; Hoenderop JG
Bone; 2015 Mar; 72():14-22. PubMed ID: 25460576
[TBL] [Abstract][Full Text] [Related]
3. GPCR kinase 2 interacting protein 1 (GIT1) regulates osteoclast function and bone mass.
Menon P; Yin G; Smolock EM; Zuscik MJ; Yan C; Berk BC
J Cell Physiol; 2010 Nov; 225(3):777-85. PubMed ID: 20568227
[TBL] [Abstract][Full Text] [Related]
4. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
[TBL] [Abstract][Full Text] [Related]
5. Osteoblast extracellular Ca2+ -sensing receptor regulates bone development, mineralization, and turnover.
Dvorak-Ewell MM; Chen TH; Liang N; Garvey C; Liu B; Tu C; Chang W; Bikle DD; Shoback DM
J Bone Miner Res; 2011 Dec; 26(12):2935-47. PubMed ID: 21956637
[TBL] [Abstract][Full Text] [Related]
6. Deletion of CD74, a putative MIF receptor, in mice enhances osteoclastogenesis and decreases bone mass.
Mun SH; Won HY; Hernandez P; Aguila HL; Lee SK
J Bone Miner Res; 2013 Apr; 28(4):948-59. PubMed ID: 23044992
[TBL] [Abstract][Full Text] [Related]
7. Lrp4 in osteoblasts suppresses bone formation and promotes osteoclastogenesis and bone resorption.
Xiong L; Jung JU; Wu H; Xia WF; Pan JX; Shen C; Mei L; Xiong WC
Proc Natl Acad Sci U S A; 2015 Mar; 112(11):3487-92. PubMed ID: 25733894
[TBL] [Abstract][Full Text] [Related]
8. DOK3 Modulates Bone Remodeling by Negatively Regulating Osteoclastogenesis and Positively Regulating Osteoblastogenesis.
Cai X; Xing J; Long CL; Peng Q; Humphrey MB
J Bone Miner Res; 2017 Nov; 32(11):2207-2218. PubMed ID: 28650106
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-6 deletion stimulates revascularization and new bone formation following ischemic osteonecrosis in a murine model.
Kuroyanagi G; Adapala NS; Yamaguchi R; Kamiya N; Deng Z; Aruwajoye O; Kutschke M; Chen E; Jo C; Ren Y; Kim HKW
Bone; 2018 Nov; 116():221-231. PubMed ID: 30125727
[TBL] [Abstract][Full Text] [Related]
10. Urokinase plasminogen activator receptor affects bone homeostasis by regulating osteoblast and osteoclast function.
Furlan F; Galbiati C; Jorgensen NR; Jensen JE; Mrak E; Rubinacci A; Talotta F; Verde P; Blasi F
J Bone Miner Res; 2007 Sep; 22(9):1387-96. PubMed ID: 17539736
[TBL] [Abstract][Full Text] [Related]
11. IL-1 plays an important role in the bone metabolism under physiological conditions.
Lee YM; Fujikado N; Manaka H; Yasuda H; Iwakura Y
Int Immunol; 2010 Oct; 22(10):805-16. PubMed ID: 20679512
[TBL] [Abstract][Full Text] [Related]
12. Disruption of LRP6 in osteoblasts blunts the bone anabolic activity of PTH.
Li C; Xing Q; Yu B; Xie H; Wang W; Shi C; Crane JL; Cao X; Wan M
J Bone Miner Res; 2013 Oct; 28(10):2094-108. PubMed ID: 23609180
[TBL] [Abstract][Full Text] [Related]
13. Osteoprotegerin deficiency attenuates strontium-mediated inhibition of osteoclastogenesis and bone resorption.
Peng S; Liu XS; Zhou G; Li Z; Luk KD; Guo XE; Lu WW
J Bone Miner Res; 2011 Jun; 26(6):1272-82. PubMed ID: 21611968
[TBL] [Abstract][Full Text] [Related]
14. Physiological function of the angiotensin AT1a receptor in bone remodeling.
Kaneko K; Ito M; Fumoto T; Fukuhara R; Ishida J; Fukamizu A; Ikeda K
J Bone Miner Res; 2011 Dec; 26(12):2959-66. PubMed ID: 21887703
[TBL] [Abstract][Full Text] [Related]
15. Skeletal inflammation and attenuation of Wnt signaling, Wnt ligand expression, and bone formation in atherosclerotic ApoE-null mice.
Liu Y; Almeida M; Weinstein RS; O'Brien CA; Manolagas SC; Jilka RL
Am J Physiol Endocrinol Metab; 2016 May; 310(9):E762-73. PubMed ID: 26956187
[TBL] [Abstract][Full Text] [Related]
16. IDH2 deficiency increases bone mass with reduced osteoclastogenesis by limiting RANKL expression in osteoblasts.
Lee SH; Lee SH; Lee JH; Park JW; Kim JE
Bone; 2019 Dec; 129():115056. PubMed ID: 31479775
[TBL] [Abstract][Full Text] [Related]
17. CCR3 deficiency is associated with increased osteoclast activity and reduced cortical bone volume in adult male mice.
Rosendahl S; Sulniute R; Eklund M; Koskinen Holm C; Johansson MJO; Kindstedt E; Lindquist S; Lundberg P
J Biol Chem; 2021; 296():100177. PubMed ID: 33303631
[TBL] [Abstract][Full Text] [Related]
18. Overloaded Orthopedic Force Induces Condylar Subchondral Bone Absorption by Stimulating Rat Mesenchymal Stem Cells Differentiating into Osteoclasts via mTOR-Regulated
Tian Y; Chen J; Yan X; Ren D; Liu M; Zhang Q; Zhang Q; Yuan X
Stem Cells Dev; 2021 Jan; 30(1):29-38. PubMed ID: 33176606
[TBL] [Abstract][Full Text] [Related]
19. The differential expression of osteoprotegerin (OPG) and receptor activator of nuclear factor kappaB ligand (RANKL) in human osteoarthritic subchondral bone osteoblasts is an indicator of the metabolic state of these disease cells.
Kwan Tat S; Pelletier JP; Lajeunesse D; Fahmi H; Lavigne M; Martel-Pelletier J
Clin Exp Rheumatol; 2008; 26(2):295-304. PubMed ID: 18565252
[TBL] [Abstract][Full Text] [Related]
20. Galectin-3 as a novel regulator of osteoblast-osteoclast interaction and bone homeostasis.
Simon D; Derer A; Andes FT; Lezuo P; Bozec A; Schett G; Herrmann M; Harre U
Bone; 2017 Dec; 105():35-41. PubMed ID: 28822790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
